Leading Late-Phase Patient Recruitment Site in New Zealand
Delivering high-quality results at speed and scale
Part of the NZCR Group, Australasia’s largest clinical trials network, Optimal Clinical Trials provides rapid startup, high recruitment, and quality results for late-phase clinical research across more than 20 therapeutic areas – including vaccines, older adults, and metabolic studies.
With access to around 75% of New Zealand’s primary care database, as well as to a diverse patient pool of over 153,000, Optimal Clinical Trials frequently achieves ‘first-patient-in’ and ‘highest recruiter’ for global clinical trials, along with patient retention rates between 95%-100%. With ISO 9001 certification and FDA audit success, Optimal Clinical Trials is also a proven rescue site, turning around underperforming studies.
For sponsors and CROs seeking a rapid start-up, New Zealand offers the unique advantage of fast-tracked regulatory and ethics approvals, averaging four to six weeks, with no IND requirement. In addition to having 72% of its diverse population willing to participate in studies, New Zealand also offers significant economic advantages, and Optimal Clinical Trials is an approved provider for the Government’s 15%–43% R&D tax incentive scheme.
Data shows that this, in combination with New Zealand’s favourable exchange rate, means trials are up to 60% less expensive to run in New Zealand than in the US, 40% cheaper than the UK, and 10% cheaper than Australia.
